Certara Acquires Specialty Contract Research Organization Synchrogenix
Purchase adds global regulatory writing and submissionservices to Certara?s drug development consulting expertise
inVentiv Clinical Selected for Regenerative Medicine Trial
inVentiv Health Clinical has been selected for an osteoarthritis Investigational New Drug Application by IntelliCell BioSciences, Inc
Perficient Acquires BioPharm Systems
BioPharm Systems, a global IT consulting and managed services provider in the life sciences industry, has been acquired by Perficient.
Perficient announced it has acquired BioPharm Systems, Inc.
Bending Over Backwards to Get Transparency Right
The European Medicines Agency is determined to minimize opposition to its next moves on releasing clinical trial data.
ICON'S Firecrest Training Recognized by TransCelerate BioPharma Inc.
Firecrest platform offers unique capabilities for improving the quality, consistency, and compliance of ICH/GCP
ICON'S Firecrest Training Recognized by TransCelerate
ICON announced that TransCelerate has certified its Firecrest GCP training as mutually acceptable for its members.
RAPS Expands to Taiwan
RAPS announced a new chapter in Taiwan, which is its first in Asia.
EFGCP Focuses on Implementing Risk-Based Monitoring
EFGCP is organizing an interactive workshop intended to develop practical strategies and approaches for risk management and risk-based monitoring in clinical trials
The Evolving Role of the Clinical Quality Professional
Linking Leaders, host of invitation-only roundtable forums for clinical trial executives, has witnessed the rapid advancement of quality approaches supporting modern clinical trials.
Challenges in the CRO Industry: An Interview with ACRO's John Lewis
While the biopharmaceutical industry faces challenges in regulation, standardization, and change, CROs are often in the middle of the change.
RAPS Taiwan Chapter Becomes First in Asia
RAPS has announced the establishment of a new chapter in Taiwan, its first in Asia.
ERT Partners with GE Healthcare on Refined Cardiac Safety Measures
An agreement between ERT and GE Healthcare has the former integrating the latter's QT Guard Plus Algorithm tool
DIA Makes Key Appointment in China
DIA China has appointed biopharmaceutical executive Haijun (Lou) Dong, PhD, as its managing director.
EMA Announces Final Steps for its Clinical Trial Data Policy
Targeted discussions with key stakeholders in May
EMA Unveils Plans to Consult Further on Data Sharing
EMA has revealed that in early May, it will launch a final round of targeted consultations on its draft policy...
Fair Market Value Conundrum: Solutions for Sponsors and Sites
Clinical trial budget development continues to frustrate industry sponsors and investigative sites.
DIA Appoints Dr. Haijun Dong as Managing Director for DIA China
Biopharmaceutical executive Dr. Haijun (Lou) Dong has been named as managing director for DIA China.
ERT Introduces GE Healthcare's QT Guard Plus Analysis System / T-Wave Morphology Analysis
Novel Approach May Help to Prevent False Positive Cardiac Safety Findings in New Drug Development
Data Sharing and Analytics for Oncology Research Launched
Project Data Sphere, an independent not-for-profit initiative, has launched a data sharing platform
Highlights from the 2014 Partnerships in Clinical Trials Conference
The Partnerships in Clinical Trials Conference was a large venue that attracted many high-level executives from biopharmaceutical companies
Clinical Trials and Tribulations: Need for a Paradigm Shift in Drug Development
The overall burden of drug development has increased exponentially over the last decade or so.
CEO Roundtable on Cancer Launches the Project Data Sphere Initiative, A New Data Sharing and Analytic Platform for Cancer Patient Benefit
Project Data Sphere, LLC, an independent not-for-profit initiative of the CEO Roundtable on Cancer?s Life Sciences Consortium, announced today the launch of a new data sharing platform
On the Ground in China Trials
Kent Thoelke spoke at the Partnerships conference regarding trial conduct differences in China.
Karyopharm Therapeutics Inc. and Clinipace Worldwide Announce Preferred Provider Agreement
Clinipace Worldwide announced it has entered into a preferred provider agreement with Karyopharm Therapeutics Inc.
Karyopharm Therapeutics Inc. Enters into Preferred Provider Agreement with Clinipace Worldwide
Technology-Amplified dCRO Model Accelerating Personalized Approach to Targeted Therapies, Including Greater Collaboration, Higher Data Quality, and Reduced Development Costs
Greenphire Partners with ERT to Boost Patient Compliance for Global Clinical Trials
Greenphire announced the launch of a strategic partnership with ERT
Greenphire, ERT Tie Patient Reporting and Compensation
Greenphire announced a strategic partnership with ERT
Gap May Exist for Therapies for Age-related Diseases
The elderly is the fastest-growing segment of the global population, but only a few of their treatments have been clinically tested in age-appropriate patients
Development of Age-appropriate Formulations and Doses for Elderly Patients Could Enable Smarter Prescription of Approved Drugs, says GBI Research
Despite the elderly being the fastest-growing segment of the global population, only a few of their treatments have been clinically trialed in age-appropriate patients
